AAPG · NASDAQ
Ascentage Pharma Group International (AAPG) Stock Price & Fundamentals
Ascentage Pharma Group International (AAPG) closed at $358.05 on Oct 9, 2026, down 1.12% from the previous close of $362.10.
Share price, past year
1Y +31.88%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $358.05 |
| Sep 30, 2026 | $351.91 |
| Aug 31, 2026 | $355.66 |
| Jul 31, 2026 | $370.88 |
| Jun 30, 2026 | $373.05 |
| May 29, 2026 | $349.74 |
| Apr 30, 2026 | $334.93 |
| Mar 31, 2026 | $320.96 |
| Feb 27, 2026 | $286.49 |
| Jan 30, 2026 | $288.52 |
| Dec 31, 2025 | $281.95 |
| Nov 28, 2025 | $276.02 |
| Oct 31, 2025 | $270.90 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $267.50 – $386.95
Market cap, P/E and dividend yield aren't shown for Ascentage Pharma Group International yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Chinese yuan.
Financials
Ascentage Pharma Group International reported revenue of CN¥980.65M for fiscal 2024, up 341.77% from fiscal 2023.
Figures are in Chinese yuan (CNY), as Ascentage Pharma Group International reports them to the SEC.
Ascentage Pharma Group International reported a net loss of CN¥405.43M in fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | CN¥980.65M | +341.8% | −CN¥405.43M | −41.3% | −CN¥1.34 | −CN¥135.65M |
| FY2023ended Dec 31, 2023 | CN¥221.98M | +5.9% | −CN¥925.64M | −417.0% | −CN¥3.28 | −CN¥772.19M |
| FY2022ended Dec 31, 2022 | CN¥209.71M | — | −CN¥882.92M | −421.0% | −CN¥3.35 | −CN¥857.20M |
Company profile
- Name
- Ascentage Pharma Group International
- Ticker
- AAPG
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 68 Xinqing Road, Suzhou Industrial Park, Suzhou , Jiangsu
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0002023311
Recent SEC filings
- Apr 29, 2026
- Apr 16, 2025
Related stocks
Ascentage Pharma Group International's industry, as the SEC classifies it, is Pharmaceutical Preparations. The companies closest to Ascentage Pharma Group International in revenue in it and related industries are Zhengye Biotechnology Holding and Yatsen Holding.
Frequently asked questions
What is Ascentage Pharma Group International's stock price?
Ascentage Pharma Group International (AAPG) closed at $358.05 on Oct 9, 2026, down 1.12% from the previous close of $362.10.
How much revenue does Ascentage Pharma Group International make?
Ascentage Pharma Group International reported revenue of CN¥980.65M for fiscal 2024, up 341.77% from fiscal 2023.
Sources and methodology
Fundamentals come from Ascentage Pharma Group International's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 10, 2026. Data sources and disclosures